Q3 EPS Estimates for DENTSPLY SIRONA Cut by William Blair

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Equities researchers at William Blair dropped their Q3 2025 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a research report issued to clients and investors on Thursday, May 8th. William Blair analyst B. Vazquez now forecasts that the medical instruments supplier will post earnings per share of $0.49 for the quarter, down from their prior forecast of $0.51. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. William Blair also issued estimates for DENTSPLY SIRONA's Q3 2026 earnings at $0.53 EPS.

A number of other research analysts have also commented on the company. StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday. Jefferies Financial Group lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their target price for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Mizuho lowered their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. Finally, Piper Sandler lowered their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $20.27.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $15.81 on Monday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a market cap of $3.15 billion, a price-to-earnings ratio of -7.64, a P/E/G ratio of 1.80 and a beta of 0.92. The business's 50-day simple moving average is $14.36 and its 200-day simple moving average is $17.54. DENTSPLY SIRONA has a 52 week low of $12.16 and a 52 week high of $28.69.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The business had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm's revenue for the quarter was down 7.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.42 EPS.

Hedge Funds Weigh In On DENTSPLY SIRONA

Hedge funds and other institutional investors have recently modified their holdings of the stock. Colonial Trust Co SC bought a new position in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. Riverview Trust Co bought a new position in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. MassMutual Private Wealth & Trust FSB lifted its position in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after buying an additional 1,232 shares during the period. UMB Bank n.a. lifted its position in shares of DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after buying an additional 564 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. bought a new position in shares of DENTSPLY SIRONA during the 1st quarter worth approximately $25,000. Institutional investors own 95.70% of the company's stock.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier bought 15,142 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This represents a 22.66% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.50% of the stock is owned by insiders.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.05%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's payout ratio is presently -14.10%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.